cardiovascular system
• at around age 14 days
|
• reduced fractional shortening at around age 14 days
|
• at around age 14 days
|
mortality/aging
• average 21-day survival (vs 40 days for homozygous Tnni3k (WT) with CASQ2 transgene only)
|
muscle
• at around age 14 days
|
• reduced fractional shortening at around age 14 days
|